Several other regulators also house market-moving information, including enforcement actions. Deal reviews are conducted by the Justice Department, the Federal Communications Commission and the Federal Trade Commission. And the Food and Drug Administration’s decisions on whether to approve new medications are closely watched by investors.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn